Detalhe da pesquisa
1.
Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I/R) injury.
J Transl Med
; 22(1): 168, 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368334